Home » Stocks » GB Sciences

GB Sciences, Inc. (GBLX)

Stock Price: $0.0307 USD 0.0007 (2.33%)
Updated Aug 11, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 8.37M
Revenue (ttm) 3.06M
Net Income (ttm) -8.73M
Shares Out 272.77M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $0.0307
Previous Close $0.0300
Change ($) 0.0007
Change (%) 2.33%
Day's Open 0.0307
Day's Range 0.0285 - 0.0320
Day's Volume 323,937
52-Week Range 0.0151 - 0.1440

More Stats

Market Cap 8.37M
Enterprise Value 16.17M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 272.77M
Float 247.01M
EPS (basic) 1344473.94
EPS (diluted) -0.05
FCF / Share -0.03
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.01
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.73
PB Ratio 1.08
Revenue 3.06M
Operating Income -11.36M
Net Income -8.73M
Free Cash Flow -6.88M
Net Cash -7.80M
Net Cash / Share -0.03
Gross Margin 6.81%
Operating Margin -370.82%
Profit Margin -378.40%
FCF Margin -224.72%
ROA -31.75%
ROE -75.01%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2018201720162015201420132012
Revenue3.452.51-----
Revenue Growth37.61%------
Gross Profit0.211.73-----
Operating Income-15.59-17.82-8.93-6.96-7.97-0.19-0.11
Net Income-23.65-22.97-9.91-6.77-7.72-0.660.04
Shares Outstanding21013379.0044.9129.520.940.97
Earnings Per Share-0.13-0.17-0.13-0.15-0.26-0.700.04
Operating Cash Flow-9.24-12.25-4.47-3.56-3.50-0.36-0.04
Capital Expenditures-10.58-3.43-3.05-0.88-0.94-0.02-
Free Cash Flow-19.82-15.68-7.52-4.45-4.44-0.38-0.04
Cash & Equivalents0.183.582.690.030.000.340.34
Total Debt6.127.553.932.610.181.271.27
Net Cash / Debt-5.94-3.97-1.24-2.58-0.18-0.93-0.93
Assets30.0224.0513.012.441.450.540.54
Liabilities12.878.424.604.413.381.551.55
Book Value8.3012.758.33-1.90-1.68-1.01-1.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name GB Sciences, Inc.
Country United States
Employees 56
CEO John Claybron Poss

Stock Information

Ticker Symbol GBLX
Stock Exchange US OTC
Unique Identifier OTCMKTS: GBLX

Description

GB Sciences, Inc. focuses to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for various ailments. It is developing technologies in plant biology, cultivation and extraction techniques, which are combined with biotechnology; and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.